GO
Loading...

Pfizer Inc

More

  • *May deter Pfizer from returning to bid for AstraZeneca. LONDON, Sept 23- Shares in drugmakers AstraZeneca and Shire both fell more than 5 percent on Tuesday after the U.S.

  • *Raiffeisen Bank sinks after warning on Ukraine, Hungary. Shares in Raiffeisen Bank International featured among the top losers, down 10 percent after the Austrian lender said hits from Ukraine and Hungary will likely push it to its first-ever annual loss in 2014..

  • LONDON, Sept 23- Shares in drugmakers AstraZeneca and Shire both fell more than 5 percent on Tuesday after the U.S. The move appears to jeopardise an agreed deal for AbbVie to buy Shire for $55 billion and could deter Pfizer from making another attempt to acquire AstraZeneca, after a $118 billion takeover attempt failed in May.

  • Final Glance: Pharmaceuticals companies Monday, 22 Sep 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 47 or. 6 percent, to $72.07. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $51.67. Hospira fell $1.39 or 2.6 percent, to $52.46.

  • Midday Glance: Pharmaceuticals companies Monday, 22 Sep 2014 | 2:12 PM ET

    Baxter International Inc. fell$. 63 or. 9 percent, to $71.91. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $51.71. Hospira fell $1.31 or 2.4 percent, to $52.54.

  • Most active New York Stock Exchange-traded stocks Monday, 22 Sep 2014 | 2:12 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Alcoa Inc. fell 2.3 percent to $15.83 with 22,421,800 shares traded. Alpha Natural Resources Inc. fell 9.4 percent to $2.70 with 22,178,100 shares traded.

  • FRANKFURT, Sept 22- Drugs and chemicals maker Merck KGaA agreed on Monday to acquire U.S.-based Sigma-Aldrich Corp for $17 billion in cash to boost its lab supplies business, the biggest takeover in the German group's history.

  • Early Glance: Pharmaceuticals companies Monday, 22 Sep 2014 | 11:05 AM ET

    Baxter International Inc. fell$. 55 or. 8 percent, to $71.99. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $51.71. Hospira fell$. 96 or 1.8 percent, to $52.89.

  • FRANKFURT, Sept 22- Drugs and chemicals maker Merck KGaA agreed on Monday to acquire U.S. company Sigma-Aldrich for $17 billion in cash to boost its lab supplies business, the biggest takeover in the German group's history.

  • Final Glance: Pharmaceuticals companies Friday, 19 Sep 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 56 or. 8 percent, to $72.54. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $51.51. Hospira rose$. 34 or. 6 percent, to $53.85.

  • Most active New York Stock Exchange-traded stocks Friday, 19 Sep 2014 | 1:33 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Bank of America Corp. fell. 5 percent to $16.95 with 85,093,900 shares traded. Coca-Cola Co. rose. 6 percent to $42.05 with 43,893,700 shares traded.

  • Midday Glance: Pharmaceuticals companies Friday, 19 Sep 2014 | 1:33 PM ET

    Baxter International Inc. fell$. 59 or. 8 percent, to $72.51. Bristol-Myers Squibb Co. rose$. 44 or. 9 percent, to $51.56. Hospira rose$. 39 or. 7 percent, to $53.90.

  • Early Glance: Pharmaceuticals companies Friday, 19 Sep 2014 | 10:16 AM ET

    Baxter International Inc. fell$. 38 or. 5 percent, to $72.72. Bristol-Myers Squibb Co. rose$. 42 or. 8 percent, to $51.54. Hospira rose$. 38 or. 7 percent, to $53.89.

  • Final Glance: Pharmaceuticals companies Thursday, 18 Sep 2014 | 6:04 PM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $73.10. Bristol-Myers Squibb Co. rose$. 24 or. 5 percent, to $51.12. Hospira rose$. 07 or. 1 percent, to $53.51.

  • NEW YORK, Sept 18- U.S. fund managers are finding a lot to like about finger-painting and naptime. Fund ownership of Bright Horizons Family Solutions Inc, the only publicly traded daycare company in the United States, swelled 21 percent in the most recently reported quarter according to fund tracker Morningstar.

  • The drug, developed by Vivus Inc, is marketed in the United States and Canada by Auxilium Pharmaceuticals Inc. Vivus' stock was up about 13 percent at $4.40 in afternoon trading.

  • The drug was developed by Auxilium Pharmaceuticals Inc and Vivus Inc.. Vivus owns the worldwide development and commercial rights to Stendra for use in sexual dysfunction, with the exception of certain Asian countries in the Pacific Rim.

  • Most active New York Stock Exchange-traded stocks Thursday, 18 Sep 2014 | 1:18 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Bank of America Corp. rose 1.6 percent to $17.04 with 108,090,900 shares traded. Citigroup Inc. rose 2.4 percent to $53.66 with 27,017,700 shares traded.

  • Midday Glance: Pharmaceuticals companies Thursday, 18 Sep 2014 | 1:18 PM ET

    Baxter International Inc. rose$. 36 or. 5 percent, to $73.01. Bristol-Myers Squibb Co. rose$. 32 or. 6 percent, to $51.20. Hospira rose$. 24 or. 4 percent, to $53.68.

  • The drug, developed by Vivus Inc, is marketed in the United States and Canada by Auxilium Pharmaceuticals Inc. Vivus' stock was up about 13 percent at $4.40 in afternoon trading.